<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02029547</url>
  </required_header>
  <id_info>
    <org_study_id>18F-AV-45-JPT01</org_study_id>
    <nct_id>NCT02029547</nct_id>
  </id_info>
  <brief_title>Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians</brief_title>
  <official_title>Evaluation of Computer-Based Training to Educate Japanese Physicians in the Methods of Interpreting Florbetapir (18F) PET Scans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avid Radiopharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avid Radiopharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to validate the Japanese electronic florbetapir (18F) interpretation
      training program intended for post-approval implementation in Japan.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inter Rater Reliability</measure>
    <time_frame>Scan acquired 50-60 minutes post injection</time_frame>
    <description>Measure of agreement among readers using a binary visual read method (amyloid positive/negative) calculated using Fleiss' kappa. All scans were read in a blinded fashion without access to clinical information.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Agreement with Expert Panel</measure>
    <time_frame>Scan acquired 50-60 minutes post-injection</time_frame>
    <description>Individual reader scan results will be compared to the expert panel's consensus rating for each scan.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in inter reader reliability after application of quantitation software</measure>
    <time_frame>Scan acquired 50-60 minutes post injection</time_frame>
    <description>Evaluate the percent change in inter reader reliability after implementation of quantitation analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in agreement with expert panel</measure>
    <time_frame>Scan acquired 50-60 minutes post-injection</time_frame>
    <description>The percent change in individual reader agreement with the expert panel's consensus rating will determined after implementation of quantitation analysis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Physician Readers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Physician readers will interpret 60 Amyvid scans using qualitative analysis followed by the use of quantitation. No subjects will be exposed to florbetapir (18F) as part of this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Florbetapir (18F)</intervention_name>
    <description>No Florbetapir (18F) will be administered in this study.</description>
    <arm_group_label>Physician Readers</arm_group_label>
    <other_name>Florbetapir F 18</other_name>
    <other_name>florbetapir</other_name>
    <other_name>Amyvid</other_name>
    <other_name>18F-AV-45</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Japanese Society of Nuclear Medicine (JSNM) Positron Emission Tomography (PET)
             Certified Nuclear Medicine Physician

          -  Minimal hands-on experience and no formal training in the visual interpretation of
             florbetapir (18F) brain PET scans

          -  Minimal hands-on experience and no formal training in the quantitation of florbetapir
             (18F) brain PET scans

        Exclusion Criteria:

          -  Prior hands-on experience or formal training in the visual interpretation and/or
             quantitation of florbetapir (18F) PET scans
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tokyo</city>
        <zip>100-0005</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2014</study_first_submitted>
  <study_first_submitted_qc>January 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2014</study_first_posted>
  <last_update_submitted>October 22, 2014</last_update_submitted>
  <last_update_submitted_qc>October 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

